Recent Patents in Allergy/Immunology: Use of arginase inhibitors in the treatment of asthma and allergic rhinitis
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Targeting arginase and nitric oxide metabolism in chronic airway diseases and their co-morbiditiesCurrent Opinion in Pharmacology, 2018
- Increased arginase activity contributes to airway remodelling in chronic allergic asthmaEuropean Respiratory Journal, 2011
- Arginase 1 and arginase 2 variations associate with asthma, asthma severity and β2 agonist and steroid responsePharmacogenetics and Genomics, 2010
- Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectivesBritish Journal of Pharmacology, 2009
- Arginase Inhibition Protects against Allergen-induced Airway Obstruction, Hyperresponsiveness, and InflammationAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Inhibition of arginase in rat and rabbit alveolar macrophages by Nω‐hydroxy‐D,L‐indospicine, effects on L‐arginine utilization by nitric oxide synthaseBritish Journal of Pharmacology, 1997
- Deficiency of nitric oxide in allergen‐induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo studyBritish Journal of Pharmacology, 1996